Ron Kurtz, MD, and Mark Livingston Join Allegro Ophthalmics’ Board of Directors
SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics, LLC, a late stage biotechnology company focused on the development of therapies to treat vitreoretinal diseases, today announced that Ron Kurtz, MD, president and CEO of Calhoun Vision, and Mark Livingston, president and CEO of PrimaPharma, have been elected to Allegro’s board of directors. “Ron and Mark bring tremendous operational, financial and leadership expertise and experience to Allegro,” said Hampar Karageozian, MSc, MBA
